About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 4133 record(s)
Req # A-2023-000229
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-109713-915, Primary Care Electronic Medical Record Data Acquisition.Organization: Public Health Agency of Canada
April 2024
Req # A-2023-000230
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-111932-241, Global Public Health Intelligence Network (GPHIN) Products Update.Organization: Public Health Agency of Canada
April 2024
Req # A-2021-000451
All documents respecting the appearance of the President of the Public Health Agency of Canada before the Special Committee on Canada-China Relations on March 22, 2021. The order adopted by the Special Committee on March 22, 2021, concerning the President’s evidence. The President’s response to the Special Committee’s March 22, 2021 order. The order adopted by the Special Committee on March 31, 2021, concerning the production of Agency documents. The Agency’s response to the Special Committee’s March 31, 2021, order. The motion adopted by the Special Committee on April 26, 2021, finding the Agency not in compliance with the Special Committee’s order. The appearances of the President and the House of Commons Law Clerk and Parliamentary Counsel before the Special Committee on May 10, 2021. The order adopted by the Special Committee on May 10, 2021, concerning the production of Agency documents. The Agency’s response to the Special Committee’s May 10, 2021, order. The Special Committee’s Third Report, presented to the House on May 26, 2021, concerning the Agency’s responses to the Special Committee’s orders. The order adopted by the House on June 2, 2021, concerning the production of Agency documents. The Agency’s response to the House’s June 2, 2021, order. The Minister of Health’s letter to the National Security and Intelligence Committee of Parliamentarians concerning the production of documents. Gérard Deltell’s question of privilege, raised in the House on June 7, 2021, concerning the Agency’s failure to comply with the document production orders. The government’s response to Mr. Deltell’s question of privilege. The appearances by the Minister of Health and the President before the Committee on June 14, 2021. The Speaker’s June 16, 2021, ruling on the question of privilege. The order adopted by the House on June 17, 2021, concerning the admonishment of the Agency, the President’s attendance at the Bar of the House, and the production of Agency documents. The appearances by the Minister of Health and the President before the Standing Committee on Health on June 18, 2021. The President’s June 20, 2021, notice to the Attorney General under the Canada Evidence Act. The June 21, 2021, letter to the Speaker on behalf of the President. The President’s attendance at the Bar of the House on June 21, 2021. The June 21, 2021, letter to the Speaker from the Leader of the Government in the House of Commons. Mr. Deltell’s question of privilege, raised in the House on June 21, 2021, concerning the production of Agency document. The proceedings brought in the Federal Court under the Canada Evidence Act concerning the production of Agency documents (Federal Court file DES-21-6). The interventions in the House on June 23, 2021, concerning the Federal Court proceedings. The motion considered in the House on June 23, 2021, concerning the adoption of the Special Committee’s Third Report. The House’s Law Clerk’s appearance before the Health Committee on June 23, 2021. The discussion at the June 28, 2021, meeting of the Board of Internal Economy concerning the Federal Court proceedings.Organization: Public Health Agency of Canada
April 2024
Req # A-2022-000356
All documents that led to NO LONGER recommending COVID vaccine boosters for children and the general population in the National Advisory Committee on Immunization (NACI) Guidance published on March 3, 2023. All documents that led to still recommending COVID vaccine boosters for children and general population in the NACI Guidance published on January 20, 2023.Organization: Public Health Agency of Canada
April 2024
Req # A-2023-000060
The contract and amendments with the following Identifications: Public Health Agency of Canada (PHAC)- Agence de la sante Publique (ASPC), C-2021-2022-Q1-00523; PHAC-ASPC, C-2021- 2022-Q1-00524 PHAC-ASPC, C-2021-2022-Q4-00693.Organization: Public Health Agency of Canada
April 2024
Req # A-2023-000090
All animal use protocols involving primates, cats and dogs from January 1, 2022 to August 15, 2023 including standard operating procedures, categories of invasiveness, criteria for endpoint decisions and sourcing information; as well as Canadian Council on Animal Care (CCAC) assessment reports, reports of major animal welfare incidents; and minutes from animal care committee meetings, veterinary site visits and information on the sentinel animal program.Organization: Public Health Agency of Canada
April 2024
Req # A-2023-000139
The contract and amendments with the following Identifications: Public Health Agency of Canada (phac)- Agence de la Sante Publique (aspc), C-2021-2022-Q1-00523; phac-aspc, C-2021-2022-Q1-00524 phac-aspc, C-2021-2022-Q4-00693.Organization: Public Health Agency of Canada
April 2024
Req # A-2023-000171
The National Microbiology Laboratory‘s report on the test COV-19CSHC, sold by the BTNX Inc.Organization: Public Health Agency of Canada
April 2024
Req # A-2023-000209
The number of excess deaths caused by cardiovascular problems since January 1, 2020.Organization: Public Health Agency of Canada
April 2024
Req # A-2023-000217
All correspondence to or from Dr. Hannah M. Exner, an employee at JC Wilt Infectious Diseases Research Centre, National Microbiology Laboratory Branch, regarding the idea, design, preparations, work underway, analysis, written paper or any other aspect of the study "Post-Market Surveillance of Six COVID-19 Point-of-Care Tests Using Pre-Omicron and Omicron SARS-CoV-2 Variants" published on January 7, 2024 in medRxiv.Organization: Public Health Agency of Canada
April 2024